The firm actively files Stryker ABG II and Rejuvenate lawsuits on behalf of those who have suffered serious complications allegedly caused by the metal-on-metal hip devices recalled in 2012.

New York, NY -- (SBWIRE) -- 12/17/2013 -- As the year closes, the Rottenstein Law Group LLP comments on the status of Stryker hip recall lawsuits in both federal and state courts, and offers its insight into the year ahead.

There are about 400 Stryker lawsuits pending in a consolidation of cases in U.S. District Court in Minnesota called a "multidistrict litigation" and more than 500 in a New Jersey consolidation called a "multicounty litigation."

In both instances, the lawsuits of common cause for suit were consolidated for efficiency in pretrial proceedings. In the MDL there is one final status conference on Dec. 19, according to court documents (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation; MDL-2441, U.S. District Court for the District of Minnesota). In the New Jersey MCL, there was recently a status conference on Dec. 16, according to court documents (In re: Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation; MCL-296, Bergen County Superior Court, New Jersey).

"Status conferences are important components of the pretrial process in case consolidations in both state and federal courts alike," said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. "In anticipation of bellwether trials to be held in 2014, the courts need to hold regular status conferences during the pretrial proceedings to keep the cases on track."

The Stryker lawsuits involve two of the company's metal-on-metal hip implant products, the Rejuvenate and the ABG II, both recalled in 2012. Claims against Stryker range from metal poisoning to device failure, according to court documents (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation; MDL-2441, U.S. District Court for the District of Minnesota). The U.S. Food and Drug Administration has issued a warning about metal-on-metal hip implants that supports claimants' allegations.*

The news follows Stryker's announcement that it will set aside between $700 million and more than $1 billion for metal-on-metal hip-related litigation, according to an Oct. 23 Wall Street Journal report.** Stryker recalled the metal-on-metal hip implants in July 2012.

Stryker hip injury claims are part of a larger problem with metal-on-metal hip implants, Rottenstein said.

"Stryker is not the only hip implant company to set aside funds for litigation costs, of course," she said. "DePuy recently agreed to a multibillion dollar settlement involving 8,000 ASR hip implant lawsuits in federal and state court."

The Rottenstein Law Group LLP encourages those who believe they have suffered from the Stryker implants' alleged side effects to visit its FAQ page to learn more about Stryker hip lawsuits and side effects, and how to contact an attorney for a free consultation. For updates on lawsuit news, visit RLG's Stryker hip lawsuit Facebook page.

-www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

-online.wsj.com/article/BT-CO-20131023-714444.html

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
plus.google.com/106070664376281033016

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The firm is currently offering vaginal mesh lawsuit evaluations to women who allege that they sustained injuries from vaginal mesh implants

New York, NY -- (ReleaseWire) -- 09/25/2013 -- There was no difference in cure rates between pelvic organ prolapse patients who underwent surgery with or without vaginal mesh, according to a newly published study. The Rottenstein Law Group LLP, a national vaginal mesh law firm, notes that there are tens of thousands of vaginal mesh injury lawsuits pending in federal and state courts across the country.

Researchers looked at a sample of POP patients over the course of three years, according to an article in the October 2013 issue of Obstetrics & Gynecology.* A portion of the women suffering from POP underwent traditional surgery to treat the condition. The rest underwent vaginal colpopexy repair with mesh. The researchers found that the mesh outcomes offered no improvement over traditional methods, according to the article.

"That this study seems to show no benefit to the use of vaginal mesh for POP surgery underscores the importance of patient vigilance," said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. "We hear daily from women who have suffered from the alleged adverse side effects of vaginal mesh—indeed, juries have awarded women damages awards because of their suffering from mesh."

There are currently six companies who are defendants in federal multidistrict litigations before Judge Joseph R. Goodwin, according to court documents pertaining to the consolidation of vaginal mesh lawsuits involving multiple mesh manufacturers.**

Women are filing transvaginal mesh lawsuits alleging they suffered adverse side effects such as pain and discomfort, in addition to vaginal erosion, according to court documents.

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged side effects of their vaginal mesh implants to visit the firm's FAQ page for quick answers to questions about mesh harms and lawsuits. For updates on vaginal mesh lawsuit news, visit RLG's vaginal mesh Facebook page.

journals.http://www.com/greenjournal/Abstract/2013/10000/Three_Year_Outcomes_of_Vaginal_Mesh_for_Prolapse_.7.aspx

C.R. Bard, American Medical Systems, Boston Scientific, Ethicon, Cook and Coloplast; MDLs-2187, 2325, 2326, 2327, 2440 and 2387; U.S. District Court for the Southern District of West Virginia.

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The firm is actively filing Stryker ABG II lawsuits for those who have suffered serious complications allegedly caused by the metal-on-metal hip device recalled in 2012

New York, NY -- (ReleaseWire) -- 09/18/2013 -- Stryker hip lawsuits are moving along in federal court in Minnesota. A status conference held on Sept. 9 oversaw the creation of some basic foundations for the federal consolidation of cases, including the selection of plaintiffs' counsel and a leadership structure, according to court documents. The Rottenstein Law Group LLP encourages those interested in getting more information on Stryker hip lawsuits and side effects to visit this page.

The consolidation, called a "multidistrict litigation," includes about 200 federal Stryker lawsuits. The Judicial Panel on Multidistrict Litigation ordered the formation in June 2013, according to court documents (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation; MDL-2441, U.S. District Court for the District of Minnesota).

"Multidistrict litigation is a method for the federal court system to increase the efficiency of a collection of lawsuits with similar claims and parties," said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. "One of the first things that the court overseeing an MDL will do is establish a framework for efficient leadership, including the selection of lead counsel and liaison counsel."

The Stryker ABG II and Rejuvenate hip implant devices have been under FDA scrutiny, owing mostly to one alleged side effect: "metal poisoning," also called "metallosis." According to the FDA,* cobalt and chromium ions could enter into the patient's bloodstream because of friction from the devices' metal parts. This could lead to potentially severe health problems.

The Rottenstein Law Group LLP represents clients nationally in Stryker hip implant lawsuits. The firm encourages those who believe they have suffered from the hip implant's alleged adverse side effects to visit the firm's FAQ page to quickly learn more about side effects and how to go about filing a lawsuit. To stay updated on Stryker hip news, visit the firm's Stryker lawsuit Facebook page.

*http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About The Rottenstein Law Group LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The firm is currently offering Avaulta vaginal mesh lawsuit evaluations to women who allege that they sustained injuries from vaginal mesh implants

New York, NY -- (ReleaseWire) -- 09/16/2013 -- Medical device manufacturer C.R. Bard and a plaintiff settled a vaginal mesh lawsuit originally scheduled to go to trial in New Jersey Superior Court on Sept. 23, according to a Bloomberg report. The Rottenstein Law Group LLP, which represents clients in vaginal mesh injury lawsuits, notes that this is the second Bard vaginal mesh settlement in less than a month.

Bard has agreed to pay plaintiff Melanie Virgil an undisclosed sum to settle her claims that her Avaulta vaginal mesh implant, manufactured by Bard, caused her problems with urination. A previous Bard lawsuit in federal court was settled for $2 million, according to Bloomberg.*

"Vaginal mesh is supposed to help treat urinary problems, not cause them," said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. "If Bard's product has resulted in serious adverse side effects, the risks of which were not made public, then the manufacturer should be held accountable. We hope that the settlement makes Ms. Virgil closer to whole again."

Bard faces more than 8,000 claims in state and federal court over the Avaulta, according to Bloomberg. . Women are filing mesh lawsuits alleging they suffered adverse side effects such as pain, discomfort and difficulty having sex, in addition to vaginal erosion, according to court documents related to federal court cases involving six different mesh manufacturers.**

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged side effects of their vaginal mesh implants to visit the firm's FAQ page at www.vaginalmeshlawsuitscenter.com/the-most-frequently-asked-tvm-questions/ for quick answers to questions about mesh harms and lawsuits. For updates on vaginal mesh lawsuit news, visit RLG's vaginal mesh Facebook page.

*bloomberg.com/news/2013-09-14/bard-said-to-settle-vaginal-mesh-case-set-for-trial.html

**C.R. Bard, American Medical Systems, Boston Scientific, Ethicon, Coloplast and Cook Medical; MDLs-2187, 2325, 2326, 2327, 2387 and 2440; U.S. District Court for the Southern District of West Virginia.

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The firm is currently offering da Vinci robot lawsuit evaluations

New York, NY -- (ReleaseWire) -- 09/11/2013 -- Outcomes from hysterectomies that use the da Vinci surgical robot versus laparoscopic surgery were similar, but with one major difference: patients involved in da Vinci surgeries were at an increased risk of pneumonia, according to a study published in the September 2013 edition of Obstetrics & Gynecology.* The Rottenstein Law Group LLP maintains a website designed to help those looking for more information on filing a da Vinci robotic surgery lawsuit or who are looking for more information on da Vinci side effects.

The study looked at more than 800,000 hysterectomies. Among the minimally invasive surgeries, the use of the surgical robot increased from about 9 percent to 13 percent, according to the study. It found that while the incident of blood transfusion was lower with robotic surgeries, the risk of acquiring postoperative pneumonia increased, the study said.

"More and more research studies and news reports are affirming the claims we hear on a daily basis from those looking to file da Vinci lawsuits," said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP.

The da Vinci features four robotic arms with precision tools and cameras that supposedly allow a surgeon to perform procedures such as hysterectomies and prostate removals less invasively than with his or her two hands alone. The device, manufactured by Intuitive Surgical, has been found to cause potentially dangerous side effects, such as internal burns, nerve damage and lacerations, according to a Sept. 9 New York Times report.** The da Vinci has been linked to 74 deaths, the report said. Additionally, da Vinci maker Intuitive Surgical recently initiated a class-2 recall of about 30 da Vinci units because of potential safety compliance issues, according to a July 12 Bloomberg story.***

The Rottenstein Law Group LLP encourages those who believe that their da Vinci robotic surgery harmed them to download a free informational brochure to quickly get their questions answered and to contact an attorney for a free consultation.

journals.lww.com/greenjournal/Abstract/publishahead/Comparison_of_Robotic_and_Laparoscopic.99682.aspx

well.blogs.nytimes.com/2013/09/09/new-concerns-on-robotic-surgeries/?_r=0

bloomberg.com/news/2013-07-12/intuitive-surgical-may-not-have-tested-devices-properly.html

About Rottenstein Law Group LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Intuitive Surgical asserts that it is fully committed to superior training opportunities for surgeons and surgical teams in the use of its products, but notes that it does not participate in determining when a surgeon is adequately prepared to operate using the da Vinci Surgical System.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm